New Delhi: Igniting hope in these testing times, Delhi chief minister Arvind Kejriwal on Friday said that the initial results of plasma therapy conducted on four coronavirus patients in the national capital have given satisfactory results, adding that similar trials will take place in the coming days.
The plasma therapy trials for COVID-19 positive patients commenced in Delhi on Tuesday. In this treatment, an antibody-rich plasma (a blood component) is taken from those who have recovered from the novel virus in order to treat critical patients.
“In the last few days, we have tried plasma therapy on four patients at Lok Nayak Jai Prakash Narayan Hospital. Till now the results are encouraging,” said CM Kejriwal.
The Delhi CM added that the central government has permitted them to run limited trials of the plasma therapy. He said that his administration will seek permission next week to use the therapy on all serious COVID-19 patients across the city.
Kejriwal also urged people who have recovered from this highly infectious virus to come forward and donate their plasma for patients who are in a critical condition.
These trials are being conducted in collaboration with the Institute of Liver and Biliary Sciences, which will be processing the blood to derive plasma and store it.
So far, India has reported 23,077 cases of coronavirus. Maharashtra continues to be the state with the highest number of COVID-19 cases in the country with 6,427 people testing positive. This is followed by Gujarat with 2,624 cases and Delhi with 2,376 cases so far.